Improving Antibiotic Prescribing for Urinary Tract Infections in Frail Elderly

NCT03970356 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1146

Last updated 2022-05-24

No results posted yet for this study

Summary

The purpose of this study is to determine whether a tailored multifaceted antibiotic stewardship intervention reduces antibiotic use for urinary tract infections in residential care homes and nursing homes attended by general practitioners. This will be evaluated in a pragmatic cluster randomised controlled trial using a modified community-based participatory action research approach.

Conditions

Interventions

OTHER

antibiotic stewardship intervention

The intervention is multifaceted, consisting of the implementation of an algorithm for restrictive use of antibiotics as proposed in recent guidelines (Verenso, Dutch guideline), tailored in close collaboration with local stakeholders to the specific implementation setting, by means of a modified participatory-action research (PAR) approach. To support the process of intervention-tailoring and -implementation, a toolbox comprising of materials, aids and actions is developed to be used at the discretion of the local stakeholders to support implementation of the algorithm.The algorithm is congruent with the Swedish and Norwegian guidelines, which also promote more restrictive use of antibiotics in case of non-specific symptoms, even though the algorithm is more detailed.

Sponsors & Collaborators

  • UMC Utrecht

    collaborator OTHER
  • Medical University of Lodz

    collaborator OTHER
  • University of Oslo

    collaborator OTHER
  • Vastra Gotaland Region

    collaborator OTHER_GOV
  • Göteborg University

    collaborator OTHER
  • Cees Hertogh

    lead OTHER

Principal Investigators

  • Cees MP Hertogh, prof. dr. · Amsterdam UMC, location VUmc

  • Theo JM Verheij, prof. dr. · UMC Utrecht

  • Maciek Godycki-Cwirko, prof.dr. · Medical University of Lodz

  • Morten Lindbæk, prof. dr. · University of Oslo

  • Pär-Daniel Sundvall, MD PhD · Göteborg University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-01
Primary Completion
2021-07-21
Completion
2021-07-21

Countries

  • Netherlands
  • Norway
  • Poland
  • Sweden

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03970356 on ClinicalTrials.gov